Domas Vaitiekus
Abstract
Results of autologous hematopoietic stem cell transplantation in Kaunas – international telemedicine project.
Domas Vaitiekus, Vilma Svetickienė, Martyna Beitnerienė, Milda Rudžianskienė, Rolandas Gerbutavičius, Elona Juozaitytė.
The Hospital of Lithuanian University of Health Sciences Kauno klinikos, Oncology and hematology department.
Aim: To present The Hospital of Lithuanian University of Health Sciences Kauno klinikos, Oncology and hematology department results of HSCT programs incorporating telemedicine project.
Methods: Retrospective analysis of 86 autologous HSCT performed for the period of 2015.07-2019.01. Patient’s characteristics, transplantation period data and survival data analyzed.
Results: Telemedicine project was started under supervision of experienced director with protocols in place 2015 August. During project flowkey elements for successful telemedicine project were identified:
Personnel Training in a JACIE accreditated HSCT center and selection of local experienced hematologists Establishment of core facilities; Site visit to the facilities;
HSCT results: Total number of transplants 86. Sex distribution: Male 48% Female 52%. Number of HSCT distribution according diseases: Multiple Myeloma 78, Lymphoma 5, testicular cancer 3. Treatment related mortality (TRM) in one hundred days (100d)- 1,16%. Multiple myeloma OS 3,5y - 90,7%
Conclusion: This innovative model of spreading of knowledge (know-how) and experience in the field of HSCT can serve as excellent example of future cellular therapies cooperation projects. Telemedicine project help to improve learning curve and avoid failures with many years experience and result are comparable with centers that are working for many decades.
Biography
Lithuanian University of Health Sciences
Head of hematopoietic stem cell transplantation sector at the Hospital of Lithuanian University of Health Sciences, Oncology and Hematology department
DATE OF BIRTH - 16th July 1985
From 2018 September - Coordinator for cellular therapies implementation at the Hospital of Lithuanian University of Health Sciences
From 2018 August
Head of hematopoietic stem cell transplantation sector at the Hospital of Lithuanian University of Health Sciences, Oncology and Hematology
2018 Mar. - 2018 May
Fellowship at Leipzig University Hospital Hematology-Oncology Department. Practice in the field of bone marrow transplantation, treatment and stem cell research. Germany
From 2017 April.
Hematologist at the Hospital of Lithuanian University of Health Sciences, Oncology and Hematology department, Eiveniu str. 2 Kaunas LT - 50009, Lithuania
2016 Sep. -2020 Sep.
The Lithuanian University of Health Sciences. PhD studies. Evaluation of genetical factors of doxorubicin cardiotoxicity in breast cancer patients.
2015 Oct -2017 Mar
Resident of Hematology at the Hospital of Lithuanian University of Health Sciences, Oncology and Hematology department, Eiveniu str. 2, Kaunas LT-50009, Lithuania
From 2014 August starting
Medical Oncologist at the Hospital of Lithuanian University of Health Sciences, Oncology and Hematology department, Eiveniu str. 2, Kaunas LT-50009, Lithuania
2010. Aug. – 2014 Aug.
Resident of Medical Oncology at the Hospital of Lithuanian University of Health Sciences, Oncology and Hematology department, Eiveniu str. 2, Kaunas LT-50009, Lithuania.
2012 Aug.-2013 Feb.
Fellowship at Leipzig University Hospital Hematology-Oncology Department. Practice in the field of bone marrow transplantation, sarcoma treatment and stem cell research. Germany
2014 Jan – 2014 Feb
Fellowship at Manchester The Christie NHS Foundation Trust Hospital. Practice in the field of bone marrow transplantation, sarcoma treatment, Germ-cell cancers. United Kingdom.
EDUCATION
1992 - 2004
Kaunas „Azuolas“ Gymnasium
2004 - 2010
Medicine master degree. Kaunas University of Medicine,
BOARD CERTIFICATION
2010
Doctor of Medicine,
2014
Medical Oncologist
2017
Hematologist
PROFESSIONAL QUALIFICATIONS
Member of European Society of Medical Oncology
Member of EBMT
Member of Lithuanian Society of Medical Oncology
Participant of ESMO Baltic-Nordic Congress, Copenhagen 2011.
Participant of Baltic States Medical Oncology Association Congress, Vilnius 2011
Participant of Baltic States Medical Oncology Association Congress, Riga 2012
Participant of ESMO 2012 congress. Vienna.
Participant of ESMO preceptorship in gastric cancer. Berlin 2012. (personal expenses)
Participant of workshop for breast imaging and biopsy. Leipzig 2012.
Participant of EURORIT forum of oncology. Zagreb 2013
ESMO Northern Europe and Baltic Meeting. Copenhagen 2014.
Prostate cancer debate. Vienna 2015.
Clinical unit visit. Cremona Italy 2015.
EBMT. Istanbul, Turkey 2015.
ESMO GI 2015 Barcelona, Spain.
ESMO GIST and Sarcoma. Milan. Italy 2016; 2018.
ESH. Copenhagen. Denmark 2016.
Melanoma meeting (speaker), Slovene Medical Association, Section for Clinical Oncology, Ljubljana, Slovenia 2016.
Cardio-oncology society meeting. Poster presentation. Tel-Aviv. Israel. 2017
ESMO 2017, Madrid, Spain.
ESMO lymphoma preceptorship 2017, Lugano, Switzerland (ESMO grant).
PROFESSIONAL INTERESTS
High dose chemotherapy with stem cell support. Cellular therapies. Cardiotoxicity. Sarcoma treatment. Cancer related anemia. Pharmacogenetics.
CLINICAL TRAIS
GMP certificate 2013 06 06 Kaunas/Biomapas 2013 07 till 2015 07 II phase clinical trial for mCRPC treatment (SI) 2014 09 till now III phase clinical trial BROCADE 3 (SI) 2016 03 till now MK-3475-062 (SI) 2016 05 HALO -301 (SI)
LANGUAGES
Lithuanian native. English – fluent. German – proficient. Russian – fluent. Polish- proficient. Spanish – basic knowledge.
